Position in IQV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$7,728
+$1,419 QoQ
Shares Held
40
+8.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#103
of 126 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $348,286 across 16 Diagnostics & Research names. IQV ranks #5 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OPK |
Opko Health, Inc.
|
116,680 | $175,020 | |
| 2 | RDNT |
RadNet, Inc.
|
979 | $60,374 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
109 | $54,648 | |
| 4 | DHR |
Danaher Corp /De/
|
89 | $16,952 | |
| 5 | IQV |
Iqvia Holdings Inc.
This page
|
40 | $7,728 | |
| 6 | NTRA |
Natera, Inc.
|
23 | $6,243 | |
| 7 | ILMN |
Illumina, Inc.
|
30 | $5,274 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
10 | $5,264 |
All Filings in IQV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,728 | 40 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $6,309 | 37 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $11,045 | 49 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $5,888 | 31 | Shares | Sole | 2025-10-14 | |
| 2025-03-31 | $1,586 | 9 | Shares | Sole | 2025-04-17 | |
| 2024-09-30 | $3,317 | 14 | Shares | Sole | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||